Showing 38,381 - 38,400 results of 101,390 for search '(( 5 wt decrease ) OR ( 5 ((we decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.86s Refine Results
  1. 38381
  2. 38382

    FoxO1a is induced by CD81 clustering, concurrent with deactivation of Akt. by Kuanyin K. Lin (200312)

    Published 2011
    “…Positive nuclear correlation in the single cell images was assigned when the similarity score was more than 1 (more than 100 cells were acquired for each analysis, <i>n</i> = 2 per group of treatment; mean values ± SD are shown, *<i>p</i><0.05). (D) On 5FU-Day8, the level of phospho-Akt in CD81<sup>+</sup>CD48<sup>−</sup>Lin<sup>−</sup>SP cells that are returning to quiescence on 5FU-Day8 is lower than that in the CD81<sup>+</sup>CD48<sup>+</sup>Lin<sup>−</sup>SP cells, a population that is proliferative. …”
  3. 38383
  4. 38384
  5. 38385

    Standardized performance precision analysis as a function of number of projects aggregated. by Austin Chou (2558950)

    Published 2022
    “…<p>As the number of projects increased, the performance precision improved (i.e. standardized performance CI width decreased). (A, B) By LogLoss, BP<sub>log</sub> started with a standardized performance precision of 5.22 ± 0.24% with 2-project aggregation and decreased to an average of 1.85 ± 0.01% with 25-project aggregation (A). …”
  6. 38386

    Model-predicted effect of once a day administration of 1000 mg of acetazolamide. by Nicholas Heming (510208)

    Published 2014
    “…Minute ventilation is predicted to increase by more than 0.75 l min<sup>−1</sup> in 65% of patients (A) and PaCO<sub>2</sub> is predicted to decrease by 5 mmHg in 45% of patients (B) supported by pressure support ventilation treated by 1000 mg day<sup>−1</sup> of acetazolamide. …”
  7. 38387

    A Conductive Bamboo Fabric with Controllable Resistance for Tailoring Wearable Sensors by Menghao Li (727830)

    Published 2022
    “…The volume resistivity (ρ<sub>v</sub>) decreases with increasing weft and linear densities, too. …”
  8. 38388

    A Conductive Bamboo Fabric with Controllable Resistance for Tailoring Wearable Sensors by Menghao Li (727830)

    Published 2022
    “…The volume resistivity (ρ<sub>v</sub>) decreases with increasing weft and linear densities, too. …”
  9. 38389

    A Conductive Bamboo Fabric with Controllable Resistance for Tailoring Wearable Sensors by Menghao Li (727830)

    Published 2022
    “…The volume resistivity (ρ<sub>v</sub>) decreases with increasing weft and linear densities, too. …”
  10. 38390

    A Conductive Bamboo Fabric with Controllable Resistance for Tailoring Wearable Sensors by Menghao Li (727830)

    Published 2022
    “…The volume resistivity (ρ<sub>v</sub>) decreases with increasing weft and linear densities, too. …”
  11. 38391

    A Conductive Bamboo Fabric with Controllable Resistance for Tailoring Wearable Sensors by Menghao Li (727830)

    Published 2022
    “…The volume resistivity (ρ<sub>v</sub>) decreases with increasing weft and linear densities, too. …”
  12. 38392

    A Conductive Bamboo Fabric with Controllable Resistance for Tailoring Wearable Sensors by Menghao Li (727830)

    Published 2022
    “…The volume resistivity (ρ<sub>v</sub>) decreases with increasing weft and linear densities, too. …”
  13. 38393
  14. 38394

    A large proportion of NSCs redivide within 24 to 72 h. by Valerio Lupperger (9745714)

    Published 2020
    “…(B–E) Example DLS (yellow arrow) for a labeling interval Δt = 9 h. (F) The DLS proportion is high for Δt = 9 h and decreases rapidly with increasing Δt. …”
  15. 38395

    Baseline characteristics. by Nattapat Nitinai (17896679)

    Published 2024
    “…The montelukast group exhibited a decreased incidence rate of transaminase elevations (0.7% vs 1.4% per day, HR: 0.48, 95%CI 0.25–0.90, P = 0.023).…”
  16. 38396

    Subgroup analyses for the primary outcome. by Nattapat Nitinai (17896679)

    Published 2024
    “…The montelukast group exhibited a decreased incidence rate of transaminase elevations (0.7% vs 1.4% per day, HR: 0.48, 95%CI 0.25–0.90, P = 0.023).…”
  17. 38397

    Outcomes. by Nattapat Nitinai (17896679)

    Published 2024
    “…The montelukast group exhibited a decreased incidence rate of transaminase elevations (0.7% vs 1.4% per day, HR: 0.48, 95%CI 0.25–0.90, P = 0.023).…”
  18. 38398

    Trial profile. by Nattapat Nitinai (17896679)

    Published 2024
    “…The montelukast group exhibited a decreased incidence rate of transaminase elevations (0.7% vs 1.4% per day, HR: 0.48, 95%CI 0.25–0.90, P = 0.023).…”
  19. 38399

    Anion-Controlled Assembly of Silver(I)/Aminobenzonitrile Compounds: Syntheses, Crystal Structures, and Photoluminescence Properties by Fu-Jing Liu (2097100)

    Published 2012
    “…Structural analysis reveals that aminobenzonitrile acts as bidentate μ<sub>2</sub>-N,N′ or monodentate μ<sub>1</sub>-N ligands in <b>1</b>–<b>5</b>. Complex <b>1</b> is a 1D chain comprised of <i>C</i><sub>2</sub>-symmetric [Ag­(<i>m</i>-abn)]<sub>2</sub> 14-membered rings. …”
  20. 38400

    Utilizing reduction in spheroid counts and/or total nuclear intensity to determine toxic effects of compounds. by Pranjali Beri (14945400)

    Published 2023
    “…They are indicated appropriately in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0287809#pone.0287809.g004" target="_blank">Fig 4</a>. …”